In #EPeeps, this pooled analysis of RCTs in #Afib patients with #HFrEF showed that catheter ablation resulted in a 43% relative risk reduction in HF hospitalizations and greater improvements in LVEF and quality of life compared to medical therapy alone! @Davilandre#CardioTwitter
In our recent meta-analysis comparing catheter ablation with medical therapy in patients with AF and HFrEF, catheter ablation was associated with a reduction in HF hospitalization, CV mortality, and all-cause mortality as well as a significant improvement in LVEF and QoL.
Our #MetaMasters team just published a groundbreaking meta-analysis in #neurology and #stroke research, shedding new light on treatment approaches and paving the way for innovative interventions. Kudos to the team for their diligent work! 🧠
Thrilled to share our latest research about the long-term impact of home-based monitoring after an admission for acute
decompensated heart failure.
Published in @eClinicalMed:
https://t.co/rVRv8PyeRq
Thrilled to announce our final paper of 2023—a stellar publication by our #MetaMasters! Huge congratulations to the entire team for their outstanding work.
Excited to kick off the new year with a trail of accomplishments, building on the success of the last one!
PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials | BMC Cancer https://t.co/xx1o9U1Y5O
Cancers | PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials https://t.co/dyyuXOtqdU
High impact team doing high impact research: this is #MetaMasters@eric_ptt
This is a publication by the students from The Meta-Analysis Academy in Endocrinology.